Soc. Generale Discount Zert FRE 3.../ DE000SV7Q5Q2 /
16/12/2024 08:18:52 | Chg.- | Bid22:00:38 | Demandez à22:00:38 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
27.98EUR | - | - Bid taille: - |
- Ask la taille: - |
FRESENIUS SE+CO.KGAA... | - - | 31/12/2024 | Call |
GlobeNewswire
24/04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page